Document is current

Article History

Received: 2 April 2020

Accepted: 28 April 2020

First Online: 12 June 2020

Compliance with ethical standards

:

: A Rodríguez-Lescure has received consultant, advisory, or speaker fees or travel and accommodation for attending symposia from Roche, Pfizer, Novartis, Lilly, Kern, Astrazeneca, Eisai, and Mylan. F Ayala de la Peña has received honoraria for speaking at symposia and educational meetings from Astrazeneca, Celgene, Eisai, Novartis, Roche, Pfizer, Pierre Fabre; research grant/funding from Celgene and Roche; meeting travel expenses from Roche, Pfizer, Celgene, Eisai, Pierre Fabre, and MSD, and financial support for educational programs or advisory boards from MSD, Pfizer, and Roche. E Aranda has received fees for advisory role from Amgen, Bayer, Celgene, Merck, Roche, and Sanofi. A. Calvo has received speaking, advisory, travel, or grant support from Lilly, Merck, BMS, Amgen, Servier, Boehringer-Ilgenheim, and Roche. E. Felip has received honoraria for advisory, consultancy, speaker bureau or expert testimony from Pfizer, Roche, Boehringer Ingelheim, Astrazeneca, BMS, Guardant Health, Novartis, Takeda, Abbvie, Blue Print medicines, Lilly, Merck KGaA, MSD, Janssen, Samsung, Medscape, Prime oncology, and Touchtime; research grant funding from Fundación Merck Salud (Grant for oncology innovation). P Garrido has received honoraria for speaker or advisory from Roche, Astrazeneca, BMS, Guardant Health, MSD, Pfizer, Janssen, Boehringer Ingelheim, Novartis, Gilead, Rovi, Abbvie, Lilly, Takeda, Sysmex, Blueprint medicines, and Bayer. R Vera has received honoraria and non-financial support from Roche, Merck, MSD, Sanofi, Servier, and BMS.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Informed consent was obtained from all individual participants included in the study.